INCY vs LUCD · P/E 14, rev $5.14B vs rev $2.7M
Incyte Corporation (INCY) versus Lucid Diagnostics Inc (LUCD) — a side-by-side from cached financials, not a winner call.
Incyte Corporation (INCY) is a biotechnology company listed on US.
Lucid Diagnostics Inc (LUCD) is a medical devices company listed on US.
Latest reported INCY revenue for 2025-12-31 was $5.14B. Net income was $1.29B. Revenue was up 21.2% from 2024-12-31 to 2025-12-31. INCY currently screens at market cap $20.45B and trailing P/E 14.5.
Latest reported LUCD revenue for 2026-06-30 was $2.7M. Net income was -$25.6M. LUCD currently screens at market cap $123.3M.
INCY currently screens at market cap $20.45B and trailing P/E 14.5. LUCD currently screens at market cap $123.3M.
Not investment advice. Open the INCY and LUCD stock pages for the full models.
Not investment advice.